Literature DB >> 30112591

Pseudomonas aeruginosa FARP72 Offers Protection Against Aeromonas hydrophila Infection in Labeo rohita.

Farhana Hoque1,2, T Jawahar Abraham3, T S Nagesh4, Dibyendu Kamilya5.   

Abstract

Use of probiotics as the biocontrol agent for disease prevention in aquaculture is gaining importance as an alternative to the indiscriminate use of antibiotics and other chemotherapeutics. In view of this trend, the probiotic properties of a potent antagonistic bacterium, Pseudomonas aeruginosa FARP72, was characterized in terms of safety, antagonistic activities, in vitro immunomodulation, and in vivo disease resistance. Immunomodulatory activity was ascertained by measuring the production of intracellular superoxide anion, nitric oxide, total leukocyte peroxidase content, and the leukocyte proliferation in head kidney leukocytes. The bacterium isolated from the skin mucus of freshwater catfish Clarias batrachus was harmless to Labeo rohita. It showed inhibitory activity against Aeromonas caviae, A. hydrophila, Edwardsiella tarda, Pseudomonas putida, and Streptococcus agalactiae as revealed by cross and parallel streaking methods. Significantly higher superoxide anion and nitric oxide production, peroxidase content, and proliferative responses of leucocytes delineated the strains' ability to interact with immune cells to activate the immune system in vitro. Significant growth inhibition of A. hydrophila from 1.55 × 105 CFU/mL was observed when co-cultured with P. aeruginosa FARP72 in phosphate-buffered saline (PBS) at levels ranging from 2.61 × 107 to 2.61 × 109 CFU/mL in 10 days. P. aeruginosa FARP72 increased the survival rate of rohu fingerlings against pathogenic A. hydrophila challenge in biocontrol study in vivo as determined by cohabitation challenge. These results suggest that P. aeruginosa FARP72 is a potential probiotic strain and can be used in aquaculture to improve the health status and disease resistance of fish.

Entities:  

Keywords:  Aeromonas hydrophila; Biocontrol; Labeo rohita; Probiotics; Pseudomonas aeruginosa

Year:  2019        PMID: 30112591     DOI: 10.1007/s12602-018-9456-1

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  21 in total

1.  Macrophage activating factor(s) secreted by mitogen stimulated goldfish kidney leukocytes synergize with bacterial lipopolysaccharide to induce nitric oxide production in teleost macrophages.

Authors:  N F Neumann; D Fagan; M Belosevic
Journal:  Dev Comp Immunol       Date:  1995 Nov-Dec       Impact factor: 3.636

2.  Effects of potential probiotic Bacillus amyloliquefaciens [corrected] FPTB16 on systemic and cutaneous mucosal immune responses and disease resistance of catla (Catla catla).

Authors:  Anushree Das; Khriezhato Nakhro; Supratim Chowdhury; Dibyendu Kamilya
Journal:  Fish Shellfish Immunol       Date:  2013-09-04       Impact factor: 4.581

3.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

4.  Use of a probiotic to control lactococcosis and streptococcosis in rainbow trout, Oncorhynchus mykiss (Walbaum).

Authors:  J Brunt; B Austin
Journal:  J Fish Dis       Date:  2005-12       Impact factor: 2.767

5.  Effects of dietary supplementation of potential probiotic Pseudomonas aeruginosa VSG-2 on the innate immunity and disease resistance of tropical freshwater fish, Labeo rohita.

Authors:  Sib Sankar Giri; Shib Sankar Sen; V Sukumaran
Journal:  Fish Shellfish Immunol       Date:  2012-03-23       Impact factor: 4.581

6.  Flavobacterium psychrophilum, invasion into and shedding by rainbow trout Oncorhynchus mykiss.

Authors:  J Madetoja; P Nyman; T Wiklund
Journal:  Dis Aquat Organ       Date:  2000-10-25       Impact factor: 1.802

7.  Fish bioaccumulation and biomarkers in environmental risk assessment: a review.

Authors:  Ron van der Oost; Jonny Beyer; Nico P E Vermeulen
Journal:  Environ Toxicol Pharmacol       Date:  2003-02       Impact factor: 4.860

8.  Trypan blue exclusion test of cell viability.

Authors:  W Strober
Journal:  Curr Protoc Immunol       Date:  2001-05

9.  Micrococcus luteus and Pseudomonas species as probiotics for promoting the growth performance and health of Nile tilapia, Oreochromis niloticus.

Authors:  Azza M Abd El-Rhman; Yassir A E Khattab; Adel M E Shalaby
Journal:  Fish Shellfish Immunol       Date:  2009-04-08       Impact factor: 4.581

Review 10.  The role of probiotics and prebiotics in inducing gut immunity.

Authors:  Angélica T Vieira; Mauro M Teixeira; Flaviano S Martins
Journal:  Front Immunol       Date:  2013-12-12       Impact factor: 7.561

View more
  4 in total

1.  Antibacterial assay guided isolation of a novel hydroxy-substituted pentacyclo ketonic compound from Pseudomonas aeruginosa MBTDCMFRI Ps04.

Authors:  Anusree V Nair; Praveen N K; Leo Antony M; K K Vijayan
Journal:  Braz J Microbiol       Date:  2020-11-25       Impact factor: 2.476

2.  Phenotypic assessment of safety and probiotic potential of native isolates from marine fish Moolgarda seheli towards sustainable aquaculture.

Authors:  Fazal Husain; Senbagam Duraisamy; Senthilkumar Balakrishnan; Sukumar Ranjith; Prahalathan Chidambaram; Anbarasu Kumarasamy
Journal:  Biologia (Bratisl)       Date:  2022-01-10       Impact factor: 1.653

3.  Aeromonas hydrophila Induces Skin Disturbance through Mucosal Microbiota Dysbiosis in Striped Catfish (Pangasianodon hypophthalmus).

Authors:  Li-Hsuan Chen; Chia-Hsuan Lin; Ru-Fang Siao; Liang-Chun Wang
Journal:  mSphere       Date:  2022-06-29       Impact factor: 5.029

4.  Chestnut Shell Tannins: Effects on Intestinal Inflammation and Dysbiosis in Zebrafish.

Authors:  Graziella Orso; Mikhail M Solovyev; Serena Facchiano; Evgeniia Tyrikova; Daniela Sateriale; Elena Kashinskaya; Caterina Pagliarulo; Hossein S Hoseinifar; Evgeniy Simonov; Ettore Varricchio; Marina Paolucci; Roberta Imperatore
Journal:  Animals (Basel)       Date:  2021-05-25       Impact factor: 2.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.